Industrial Organization: Contemporary Theory and Empirical Applications, 5th Edition

Index

Abbreviated New Drug Application (ANDA), 322

Abrantes-Metz, 374

Ackerberg, D., 515, 537–539, 540–241, 540n21

Adams, W. J., 187

advertising, 516–547 see also economic role of advertising

complements, coordination, and industry dynamics, 535–537

information and, 516–547

information

prestige and, 537–541

price competition and, 531–535

informative advertising and price competition, 546–547

joint advertising and pricing decisions, 535

market power and, 519–520

monopoly firm's profit-maximizing level of, 520–522

practice and theory, 518–519

affiliated values, 646–647

aftermarket restrictions, 486

Agency theory, 451–452

Aggarwal, R. K., 450

aggregate demand, 102

Aghion, P., 332

Ahimud, Y., 450, 450n10

Aiginger, 60–61

Albrecht and Khan cases, 464

Albrecht v. The Herald Co., 461

Alchian, A. A., 65

Allen, R. G. D., 195n8

Allen-Myland v. IBM 33 F.3d 194 (3rd Cir.1994), 500

allocational concept, 30n9

Almost Ideal Demand System (AIDS), 415

American Economic Association, 96

American Tobacco Company v. United States, 328

U.S. 781 (1946), 10, 10n10

Anderson, S., 529

Andrade, G., 412

anticompetitive effects of vertical mergers, 432–436

antitrust and industrial organization theory, 6–13

antitrust around the globe, 13–14

Antitrust Law Index, 13–14

Chicago School and beyond, 10–13

focus in the beginning (Section 1 statute), 7

key antitrust statutes, excerpts from, 15–18; Clayton Act, including key amendments of Robinson-Patman Act and Celler-Kefauver Act, 16–18; The Sherman Act, 16

monopolization ...